Cas:19652-13-2 5-(4-methoxyphenyl)-2-phenylpyrazol-3-amine manufacturer & supplier

Chemical Name:5-(4-methoxyphenyl)-2-phenylpyrazol-3-amine

CAS.NO:19652-13-2

Synonyms:5-amino-3-(4-methoxylphenyl)-1-phenyl-1H-pyrazole;5-(4-methoxy-phenyl)-2-phenyl-2H-pyrazol-3-ylamine;3-(4-METHOXYPHENYL)-1-PHENYL-1H-PYRAZOL-5-YLAMINE;3-(4-methoxyphenyl)-1-phenylpyrazole-5-ylamine;5-(4-Methoxy-phenyl)-2-phenyl-2H-pyrazol-3-ylamin;5-Amino-3-(4-methoxyphenyl)-1-phenylpyrazole;3-(4-METHOXYPHENYL)-1-PHENYL-1H-PYRAZOL-5-AMINE;MFCD00197061

Molecular Formula:C₁₆H₁₅N₃O

Molecular Weight:265.31000

HS Code:2933199090

Physical and Chemical Properties:

Melting point:192-196ºC(lit.)

Boiling point:483.568ºC at 760 mmHg

Density:1.192g/cm3

Index of Refraction:1.626

PSA:53.07000

Exact Mass:265.12200

LogP:3.71130

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:NONH for all modes of transpor

Packing Group:

Contact us for information like 5-amino-3-(4-methoxylphenyl)-1-phenyl-1H-pyrazole chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,MFCD00197061 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,5-amino-3-(4-methoxylphenyl)-1-phenyl-1H-pyrazole Use and application,3-(4-METHOXYPHENYL)-1-PHENYL-1H-PYRAZOL-5-YLAMINE technical grade,usp/ep/jp grade.

Related News: From the three-month point onward, 84.5% of uMRD patients maintained that deep remission in the blood to the 12-month assessment. These data show the new combo can deliver “very durable remissions” for the vast majority of patients, Tendler said. 5-(4-methoxyphenyl)-2-phenylpyrazol-3-amine manufacturer The ban will be in place for up to 14 days, and is aimed at helping contain the spread of the Wuhan coronavirus. So far, there have been no confirmed coronavirus cases in New Zealand or any South Pacific island. 5-(4-methoxyphenyl)-2-phenylpyrazol-3-amine supplier At the same time, through years of imitation and advanced technology learning, more and more domestic companies have participated in the field of highly original and characteristic APIs. 5-(4-methoxyphenyl)-2-phenylpyrazol-3-amine vendor From the three-month point onward, 84.5% of uMRD patients maintained that deep remission in the blood to the 12-month assessment. These data show the new combo can deliver “very durable remissions” for the vast majority of patients, Tendler said. 5-(4-methoxyphenyl)-2-phenylpyrazol-3-amine factory Pharmaceutical intermediates: chemical raw materials or chemical products used in the process of pharmaceutical synthesis, are intermediate products in the process of producing APIs, and can be further processed into APIs.